TQB3454 tablets

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB3454 tablets, covering 2024-01-23 to 2024-01-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TQB3454 Tablets in Patients With Blood Tumors [Phase 1, Phase 2]